Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID‐19: An Analysis of the National COVID Cohort Collaborative (N3C)

Pharmacoepidemiology and Drug Safety(2024)10.1002/pds.5869Source: DataRank Database

Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID‐19: An Analysis of the National COVID Cohort Collaborative (N3C) is a research paper published in Pharmacoepidemiology and Drug Safety (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (74 grants)Impact (FWCI 0.91)OA: bronzeTopics (60)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

G. Caleb Alexander ORCID,Hemalkumar B. Mehta ORCID,Xuya Xiao ORCID

Live enrichment

PubMed:39099263 OpenAlex:https://openalex.org/W4401344031

National Institute on Aging

Grant: K01 AG070329

NCATS NIH HHS

Grant: UL1 TR002649

NCATS NIH HHS

Grant: UL1 TR001422

NCATS NIH HHS

Grant: UL1 TR001860

NCATS NIH HHS

Grant: UL1 TR001427

NIGMS NIH HHS

Grant: U54 GM104942

NCATS NIH HHS

Grant: UL1 TR001420

NCATS NIH HHS

Grant: UL1 TR001439

NCATS NIH HHS

Grant: UL1 TR002243

NCATS NIH HHS

Grant: UL1 TR001445

NCATS NIH HHS

Grant: UL1 TR003096

NCATS NIH HHS

Grant: UM1 TR004556

NIGMS NIH HHS

Grant: U54 GM104938

NCATS NIH HHS

Grant: UL1 TR002537

NCATS NIH HHS

Grant: UL1 TR001412

NCATS NIH HHS

Grant: UL1 TR001872

NCATS NIH HHS

Grant: UL1 TR001878

NCATS NIH HHS

Grant: UL1 TR002529

NCATS NIH HHS

Grant: UL1 TR001863

NCATS NIH HHS

Grant: UL1 TR002494

NCATS NIH HHS

Grant: UL1 TR002736

NIGMS NIH HHS

Grant: U54 GM115516

NCATS NIH HHS

Grant: UL1 TR002369

NCATS NIH HHS

Grant: UL1 TR002541

NIGMS NIH HHS

Grant: U54 GM115371

NCATS NIH HHS

Grant: UL1 TR002001

NCATS NIH HHS

Grant: UL1 TR002538

NIGMS NIH HHS

Grant: U54 GM115458

NCATS NIH HHS

Grant: UL1 TR001442

NCATS NIH HHS

Grant: UL1 TR002535

NCATS NIH HHS

Grant: UL1 TR001866

NCATS NIH HHS

Grant: UL1 TR003167

NCATS NIH HHS

Grant: UL1 TR001409

NCATS NIH HHS

Grant: UL1 TR001449

NCATS NIH HHS

Grant: UL1 TR001453

NCATS NIH HHS

Grant: UL1 TR002489

NIGMS NIH HHS

Grant: U54 GM104940

NCATS NIH HHS

Grant: UL1 TR003107

NCATS NIH HHS

Grant: UL1 TR003015

NCATS NIH HHS

Grant: UL1 TR002733

NCATS NIH HHS

Grant: UL1 TR001433

NCATS NIH HHS

Grant: U24 TR002306

NCATS NIH HHS

Grant: UL1 TR002003

NCATS NIH HHS

Grant: UL1 TR001876

NCATS NIH HHS

Grant: UL1 TR001436

NCATS NIH HHS

Grant: UL1 TR002378

NCATS NIH HHS

Grant: UL1 TR002384

NCATS NIH HHS

Grant: UL1 TR002553

NCATS NIH HHS

Grant: UL1 TR002389

NCATS NIH HHS

Grant: UL1 TR001414

NIGMS NIH HHS

Grant: U54 GM104941

NCATS NIH HHS

Grant: UL1 TR002014

NCATS NIH HHS

Grant: UL1 TR002550

NCATS NIH HHS

Grant: UL1 TR002319

NCATS NIH HHS

Grant: UL1 TR001855

NCATS NIH HHS

Grant: UL1 TR001425

NCATS NIH HHS

Grant: UL1 TR002373

NCATS NIH HHS

Grant: UL1 TR002240

NCATS NIH HHS

Grant: UL1 TR002556

NCATS NIH HHS

Grant: UL1 TR003017

NCATS NIH HHS

Grant: UL1 TR001998

NCATS NIH HHS

Grant: UL1 TR001873

NCATS NIH HHS

Grant: UL1 TR001881

NCATS NIH HHS

Grant: UL1 TR002645

NCATS NIH HHS

Grant: UL1 TR001450

NCATS NIH HHS

Grant: UL1 TR002366

NIGMS NIH HHS

Grant: U54 GM115428

NCATS NIH HHS

Grant: UL1 TR002345

NCATS NIH HHS

Grant: UL1 TR002377

NIGMS NIH HHS

Grant: U54 GM115677

NCATS NIH HHS

Grant: UL1 TR002544

NCATS NIH HHS

Grant: UL1 TR003098

NCATS NIH HHS

Grant: UL1 TR001430

NCATS NIH HHS

Grant: UL1 TR003142

FWCI

0.91

Citation Percentile

0.7%

Citation Trend

2025

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5869

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5869

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5869

journalhttps://doi.org/10.1002/pds.5869

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39099263

Fields of Study

COVID-19 Clinical Research StudiesRespiratory viral infections researchSARS-CoV-2 and COVID-19 ResearchHumansMaleFemaleMiddle AgedRetrospective StudiesCOVID-19 Drug TreatmentAdultAgedRitonavirDrug CombinationsCOVID-19Cohort StudiesLopinavirSeverity of Illness IndexDisease ProgressionUnited StatesYoung Adult

MeSH Terms

COVID-19COVID-19 Drug TreatmentAdultAgedDrug CombinationsFemaleHumansMaleMiddle AgedRetrospective StudiesSeverity of Illness IndexUnited StatesCohort StudiesDisease ProgressionRitonavirYoung AdultLopinavir

Keywords

MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakRitonavirSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacoepidemiologyPandemicEthnic groupCohort studyDiseaseInternal medicineVirologyInfectious disease (medical specialty)PharmacologyViral loadHuman immunodeficiency virus (HIV)OutbreakMedical prescriptionCOVID‐19disparitynirmatrelvir/ritonavirpaxlovidunderuse

Sustainable Development Goals

SDG 0: Good health and well-being